Richard Grimes

Richard Grimes is a seasoned professional in pharmaceutical project management, currently serving as Senior Director of Global Product Team Leadership at Crinetics Pharmaceuticals since November 2022, focusing on TSHR antagonists and SST3 agonist programs. Prior experience includes Senior Director roles at Immunomic Therapeutics, where Richard established and led the Global Project Management Office, and at Cellarity. Richard has also held significant positions at AstraZeneca as Associate Director for Biologics Project Management, leading teams in cardiovascular and metabolic disease projects, and at MedImmune as Senior Project Manager for the respiratory and autoimmune portfolio. Richard's early career includes various roles at GlaxoSmithKline, contributing to R&D strategy and scientific licensing. Richard holds a degree in Organic and Medicinal Chemistry from The University of Manchester.